Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 234 followers

Latest posts

Last updated about 18 hours ago

Training and resources for patients and consumers

about 18 hours ago

Training and resources for patients and consumers

Human medicines European public assessment report (EPAR): Pramipexole Teva, pramipexole, Date of authorisation: 18/12/2008, Revision: 23, Status: Authorised

about 18 hours ago

Human medicines European public assessment report (EPAR): Pramipexole Teva, pramipexole, Date of...

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 22, Status: Authorised

about 18 hours ago

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of...

Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorised

about 19 hours ago

Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation...

Guide on access to unpublished documents

about 19 hours ago

Guide on access to unpublished documents

Human medicines European public assessment report (EPAR): Emend, aprepitant, Date of authorisation: 11/11/2003, Revision: 31, Status: Authorised

about 19 hours ago

Human medicines European public assessment report (EPAR): Emend, aprepitant, Date of authorisation...

Emend (aprepitant) supply shortage

about 19 hours ago

Emend (aprepitant) supply shortage

Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 19, Status: Authorised

about 20 hours ago

Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation...

Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 52, Status: Authorised

about 21 hours ago

Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation...

Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorised

about 21 hours ago

Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation...

New recommendations to strengthen supply chains of critical medicines

about 21 hours ago

New recommendations to strengthen supply chains of critical medicines